Yahoo Malaysia Web Search

Sign In

Search results

  1. www.illumina.com › content › damWho we are - Illumina

    3. $200 USD genome on NovaSeq X Series is delivered at list price on 25B flow cell. Data on file. Illumina, Inc. 2023. 4. Main campus locations currently include San Diego, Foster City, Hayward, UK Illumina Centre, Netherlands, and Singapore Woodlands. M-GL-01040 v3.0 $100 million USD2 $200 USD3 Applications • Oncology • Genetic disease

  2. www.illumina.com › products › by-typeDRAGEN secondary analysis | Software for NGS data analysis - ...

    Feb 12, 2018 · Meet Illumina DRAGEN. Illumina DRAGEN (Dynamic Read Analysis for GENomics) secondary analysis enables labs of all sizes and disciplines to maximize the value of the genome with powerful, cutting-edge data analysis tools. DRAGEN secondary analysis provides accurate, comprehensive, and highly efficient bioinformatics with multiple deployment ...

  3. www.nasdaq.com › market-activity › stocksIllumina, Inc. Common Stock (ILMN) - Nasdaq

    Discover real-time Illumina, Inc. Common Stock (ILMN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

  4. www.illumina.com › company › news-centerPress Release - Illumina

    Sep 29, 2022 · SAN DIEGO, Sept. 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more ...

  5. www.illumina.com › science › technologyIllumina Microarray Technology

    Bead-Based Microarray Technology. Illumina microarray technology (also known as BeadArray technology) uses silica microbeads. On the surface of each array, or BeadChip, hundreds of thousands to millions of genotypes for a single individual can be assayed at once. These tiny silica beads are housed in carefully etched microwells and coated with ...

  6. investor.illumina.com › news › press-release-detailsIllumina, Inc. - Illumina Acquires GRAIL to Accelerate Patient...

    Aug 18, 2021 · GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission's ongoing regulatory review. Illumina, the global leader in DNA ...

  7. www.bloomberg.com › quote › ILMN:USILMN: Illumina Inc Stock Price Quote - NASDAQ GS - Bloomberg

    3 days ago · Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.